Eydelman Mikhail
Insider CIK 1918033 · PCVX SVP, Gen Counsel & Corp Sec
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-03-05 | 2025-03-07 | 5,000 | — | $0 | 144,497 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 2,267 | $71.07 | $161.1K | 41,732 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-03-05 | 2025-03-07 | 5,000 | $21.41 | $107.0K | 46,620 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 2,621 | $70.39 | $184.5K | 43,999 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-03-05 | 2025-03-07 | 112 | $72.37 | $8.1K | 41,620 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-03-03 | 2025-03-03 | 616 | $72.10 | $44.4K | 41,620 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-02-28 | 2025-03-03 | 470 | $73.02 | $34.3K | 42,236 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2025-02-27 | 2025-03-03 | 48,357 | — | $0 | 48,357 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2025-02-27 | 2025-03-03 | 14,484 | — | $0 | 42,706 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-02-05 | 2025-02-07 | 5,000 | — | $0 | 149,497 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 1,755 | $89.95 | $157.9K | 30,261 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-02-05 | 2025-02-07 | 5,000 | $21.41 | $107.0K | 33,222 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 571 | $87.77 | $50.1K | 32,651 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 635 | $89.09 | $56.6K | 32,016 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 1,784 | $91.05 | $162.4K | 28,477 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-02-05 | 2025-02-07 | 255 | $91.71 | $23.4K | 28,222 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2025-01-06 | 2025-01-07 | 5,000 | — | $0 | 154,497 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-06 | 2025-01-07 | 125 | $86.52 | $10.8K | 28,222 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2025-01-06 | 2025-01-07 | 5,000 | $21.41 | $107.0K | 33,222 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-06 | 2025-01-07 | 3,921 | $85.73 | $336.1K | 28,347 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-01-06 | 2025-01-07 | 954 | $84.86 | $81.0K | 32,268 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-12-09 | 2024-12-09 | 475 | $92.06 | $43.7K | 28,222 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-12-05 | 2024-12-09 | 5,000 | — | $0 | 159,497 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-05 | 2024-12-09 | 1,435 | $90.16 | $129.4K | 32,262 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-12-05 | 2024-12-09 | 5,000 | $21.41 | $107.0K | 33,697 | SEC↗ |
| PCVX Vaxcyte, Inc. | G Gift | 2024-12-05 | 2024-12-09 | 110 | — | $0 | 28,697 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-05 | 2024-12-09 | 388 | $92.90 | $36.0K | 28,697 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-12-05 | 2024-12-09 | 3,177 | $91.91 | $292.0K | 29,085 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-11-07 | 2024-11-08 | 26,125 | — | $0 | 26,125 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-11-05 | 2024-11-06 | 5,000 | — | $0 | 164,497 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-11-05 | 2024-11-06 | 5,000 | $21.41 | $107.0K | 33,623 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-05 | 2024-11-06 | 1,273 | $107.50 | $136.8K | 28,623 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-05 | 2024-11-06 | 1,524 | $106.82 | $162.8K | 29,896 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-05 | 2024-11-06 | 1,415 | $105.72 | $149.6K | 31,420 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-11-05 | 2024-11-06 | 788 | $104.80 | $82.6K | 32,835 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-07 | 2024-10-08 | 5,000 | — | $0 | 169,497 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 314 | $110.51 | $34.7K | 28,690 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 996 | $108.69 | $108.3K | 32,151 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 3,147 | $109.55 | $344.8K | 29,004 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 476 | $107.51 | $51.2K | 33,147 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-07 | 2024-10-08 | 5,000 | $21.41 | $107.0K | 33,623 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 67 | $111.68 | $7.5K | 28,623 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-03 | 5,500 | — | $0 | 174,497 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 1,414 | $113.38 | $160.3K | 32,709 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 1,030 | $115.01 | $118.5K | 28,623 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 3,056 | $114.37 | $349.5K | 29,653 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-10-01 | 2024-10-03 | 5,500 | $21.41 | $117.8K | 34,123 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-09-03 | 2024-09-05 | 1,667 | — | $0 | 179,997 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 144 | $116.01 | $16.7K | 30,906 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 79 | $114.96 | $9.1K | 31,050 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 122 | $112.66 | $13.7K | 31,129 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 715 | $111.57 | $79.8K | 31,251 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 80 | $117.28 | $9.4K | 30,826 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 4 | $107.67 | $431 | 32,489 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-09-03 | 2024-09-05 | 1,667 | $21.41 | $35.7K | 32,493 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-09-03 | 2024-09-05 | 2,203 | $110.15 | $242.7K | 28,623 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 523 | $110.45 | $57.8K | 31,966 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-08-01 | 2024-08-05 | 1,667 | — | $0 | 181,664 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-08-01 | 2024-08-05 | 1,482 | $78.80 | $116.8K | 31,011 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-08-01 | 2024-08-05 | 1,667 | $21.41 | $35.7K | 32,493 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-08-01 | 2024-08-05 | 185 | $79.29 | $14.7K | 30,826 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-07-01 | 2024-07-02 | 1,667 | — | $0 | 183,331 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 913 | $75.93 | $69.3K | 31,580 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-07-01 | 2024-07-02 | 1,667 | $21.41 | $35.7K | 32,493 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 754 | $76.90 | $58.0K | 30,826 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-06-07 | 2024-06-10 | 335 | $70.97 | $23.8K | 30,826 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-06-03 | 2024-06-05 | 1,667 | — | $0 | 184,998 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 260 | $73.64 | $19.1K | 31,161 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 656 | $72.37 | $47.5K | 31,421 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 751 | $71.25 | $53.5K | 32,077 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-06-03 | 2024-06-05 | 1,667 | $21.41 | $35.7K | 32,828 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-05-01 | 2024-05-03 | 1,667 | — | $0 | 186,665 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 964 | $61.30 | $59.1K | 31,300 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-05-01 | 2024-05-03 | 1,667 | $21.41 | $35.7K | 32,264 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 559 | $61.95 | $34.6K | 30,741 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 144 | $63.90 | $9.2K | 30,597 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-04-01 | 2024-04-03 | 1,667 | — | $0 | 188,332 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 270 | $67.42 | $18.2K | 30,597 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-04-01 | 2024-04-03 | 1,667 | $21.41 | $35.7K | 32,264 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 1,397 | $66.59 | $93.0K | 30,867 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-03-02 | 2024-03-04 | 613 | $71.55 | $43.9K | 30,597 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-04 | 1,667 | — | $0 | 189,999 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 703 | $73.59 | $51.7K | 31,655 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 445 | $74.77 | $33.3K | 31,210 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 519 | $73.03 | $37.9K | 32,358 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-03-01 | 2024-03-04 | 1,667 | $21.41 | $35.7K | 32,877 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-02-29 | 2024-03-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2024-02-29 | 2024-03-04 | 10,500 | — | $0 | 31,210 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-02-01 | 2024-02-05 | 1,667 | — | $0 | 191,666 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 212 | $72.22 | $15.3K | 22,165 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-02-01 | 2024-02-05 | 1,667 | $21.41 | $35.7K | 22,377 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 638 | $73.17 | $46.7K | 21,527 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 343 | $74.11 | $25.4K | 21,184 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-02-01 | 2024-02-05 | 474 | $75.39 | $35.7K | 20,710 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-01-02 | 2024-01-04 | 1,667 | — | $0 | 193,333 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 598 | $63.59 | $38.0K | 21,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 141 | $62.91 | $8.9K | 22,236 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-01-02 | 2024-01-04 | 1,667 | $21.41 | $35.7K | 22,377 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 928 | $64.31 | $59.7K | 20,710 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-12-07 | 2023-12-11 | 10,000 | — | $0 | 195,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-12-07 | 2023-12-11 | 10,000 | $56.50 | $565.0K | 21,035 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2023-12-07 | 2023-12-11 | 325 | $56.78 | $18.5K | 20,710 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-12-07 | 2023-12-11 | 10,000 | $21.41 | $214.1K | 31,035 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2023-10-02 | 2023-10-04 | 20,000 | — | $0 | 205,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2023-10-02 | 2023-10-04 | 20,000 | $21.41 | $428.2K | 40,487 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 7,992 | $49.58 | $396.2K | 32,495 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 4,874 | $50.22 | $244.8K | 27,621 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 7,134 | $51.44 | $367.0K | 20,487 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2023-09-05 | 2023-09-06 | 1,189 | $51.00 | $60.6K | 20,487 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2023-06-07 | 2023-06-09 | 645 | $51.25 | $33.1K | 21,676 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 82,500 | — | $0 | 82,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2023-03-01 | 2023-03-03 | 13,750 | — | $0 | 21,782 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-12-30 | 2023-01-04 | 27,500 | — | $0 | 27,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2022-06-07 | 2022-06-09 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2022-05-09 | 2022-05-11 | 225,000 | — | $0 | 225,000 | SEC↗ |